首页 > 最新文献

European Heart Journal: Acute Cardiovascular Care最新文献

英文 中文
Prognostic Pathways in Acute Dyspnoea: Differentiating Intravascular from Extravascular Congestion in the Emergency Department. 急性呼吸困难的预后途径:在急诊科区分血管内充血和血管外充血。
IF 4.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-06 DOI: 10.1093/ehjacc/zuaf147
Kristina Miger, Anne Sophie Overgaard Olesen, Johannes Grand, Olav W Nielsen
{"title":"Prognostic Pathways in Acute Dyspnoea: Differentiating Intravascular from Extravascular Congestion in the Emergency Department.","authors":"Kristina Miger, Anne Sophie Overgaard Olesen, Johannes Grand, Olav W Nielsen","doi":"10.1093/ehjacc/zuaf147","DOIUrl":"https://doi.org/10.1093/ehjacc/zuaf147","url":null,"abstract":"","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":""},"PeriodicalIF":4.6,"publicationDate":"2025-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145476906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why do guidelines ignore the management of Type-2 Myocardial Infarction? 为什么指南忽视了2型心肌梗死的治疗?
IF 4.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-30 DOI: 10.1093/ehjacc/zuaf138
Harvey D White
{"title":"Why do guidelines ignore the management of Type-2 Myocardial Infarction?","authors":"Harvey D White","doi":"10.1093/ehjacc/zuaf138","DOIUrl":"https://doi.org/10.1093/ehjacc/zuaf138","url":null,"abstract":"","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":""},"PeriodicalIF":4.6,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145408416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rationale for and approach to establishing a multidisciplinary acute pulmonary embolism expert care team. 建立多学科急性肺栓塞专家护理团队的基本原理和方法。
IF 4.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-29 DOI: 10.1093/ehjacc/zuaf141
F A Klok, Andrew Sharp, Ingo Ahrens, Milica Aleksic, Fionnuala Ni Ainle, Stefano Barco, Laurent Bertoletti, Brent Keeling, Karl Fengler, Julie Helms, David Jiménez, Irene M Lang, Mandy N Lauw, Roberto Lorusso, Ignacio Martin-Loeches, Lilian J Meijboom, Nicolas Meneveau, Jose Montero-Cabezas, Gerry O'Sullivan, Roberto Pola, Piotr Pruszczyk, Olivier Sanchez, Oliver Schlager, Jacob Schultz, Umit Yasar Sinan, Maria Cristina Vedovati, Peter Verhamme, Ahmed Zaher, Menno V Huisman, S V Konstantinides

Patients with acute pulmonary embolism (PE) may present with cardiac arrest, overt or impending cardiogenic shock and/or severe respiratory insufficiency. Immediate evaluation and management of these patients require high clinical suspicion along with (bedside) imaging to confirm the diagnosis, targeted haemodynamic and/or respiratory support, appropriate anticoagulant treatment, and in many cases reperfusion therapy. The immediate treatment decision-making is largely driven by local expertise and resources and should be guided by the individual patient's characteristics such as cardiopulmonary comorbidities, risk of bleeding and location, extent and hemodynamic impact of the clot. Over the past years, treatment options for patients with severe PE have expanded substantially. For instance, several new catheter-guided reperfusion therapies have emerged and experience with circulatory mechanical support has increased. Along with the rise of new interventional therapies has come the introduction of expert multidisciplinary pulmonary embolism (EXPERT-PE) care teams, composed of multidisciplinary specialists involved in treating severe acute PE. This model of care provides a platform for rapid decisions on individualized treatment strategies, combining expert opinion from all involved specialties, setting the quality standards for modern local and regional equity PE care, and forming the base for future research in this area. Clinical decisions should be evidence-based where possible, and incorporate the individual patient's and their carer's preferences, values, and priorities, as well as those of the managing clinicians and care team. In this review, we summarize the evidence for the introduction of EXPERT-PE care teams and provide a practical manual for their successful implementation.

急性肺栓塞(PE)患者可能出现心脏骤停、明显或即将发生的心源性休克和/或严重呼吸功能不全。对这些患者的立即评估和管理需要高度的临床怀疑以及(床边)影像学来确认诊断,有针对性的血流动力学和/或呼吸支持,适当的抗凝治疗,在许多情况下还需要再灌注治疗。即时的治疗决策在很大程度上取决于当地的专业知识和资源,并应根据患者的个体特征,如心肺合并症、出血风险和位置、血栓的范围和血流动力学影响等进行指导。在过去的几年中,严重PE患者的治疗选择已经大大扩大。例如,一些新的导管引导再灌注疗法已经出现,循环机械支持的经验也有所增加。随着新的介入治疗方法的兴起,引入了多学科专家肺栓塞(expert -PE)护理小组,由多学科专家组成,参与治疗严重急性肺栓塞。这种护理模式为个性化治疗策略的快速决策提供了一个平台,结合了所有相关专业的专家意见,为现代地方和区域公平的体育护理制定了质量标准,并为该领域的未来研究奠定了基础。临床决策应尽可能以证据为基础,并结合患者个人及其护理人员的偏好、价值观和优先事项,以及管理临床医生和护理团队的偏好、价值观和优先事项。在这篇综述中,我们总结了引入EXPERT-PE护理团队的证据,并为其成功实施提供了实用手册。
{"title":"Rationale for and approach to establishing a multidisciplinary acute pulmonary embolism expert care team.","authors":"F A Klok, Andrew Sharp, Ingo Ahrens, Milica Aleksic, Fionnuala Ni Ainle, Stefano Barco, Laurent Bertoletti, Brent Keeling, Karl Fengler, Julie Helms, David Jiménez, Irene M Lang, Mandy N Lauw, Roberto Lorusso, Ignacio Martin-Loeches, Lilian J Meijboom, Nicolas Meneveau, Jose Montero-Cabezas, Gerry O'Sullivan, Roberto Pola, Piotr Pruszczyk, Olivier Sanchez, Oliver Schlager, Jacob Schultz, Umit Yasar Sinan, Maria Cristina Vedovati, Peter Verhamme, Ahmed Zaher, Menno V Huisman, S V Konstantinides","doi":"10.1093/ehjacc/zuaf141","DOIUrl":"https://doi.org/10.1093/ehjacc/zuaf141","url":null,"abstract":"<p><p>Patients with acute pulmonary embolism (PE) may present with cardiac arrest, overt or impending cardiogenic shock and/or severe respiratory insufficiency. Immediate evaluation and management of these patients require high clinical suspicion along with (bedside) imaging to confirm the diagnosis, targeted haemodynamic and/or respiratory support, appropriate anticoagulant treatment, and in many cases reperfusion therapy. The immediate treatment decision-making is largely driven by local expertise and resources and should be guided by the individual patient's characteristics such as cardiopulmonary comorbidities, risk of bleeding and location, extent and hemodynamic impact of the clot. Over the past years, treatment options for patients with severe PE have expanded substantially. For instance, several new catheter-guided reperfusion therapies have emerged and experience with circulatory mechanical support has increased. Along with the rise of new interventional therapies has come the introduction of expert multidisciplinary pulmonary embolism (EXPERT-PE) care teams, composed of multidisciplinary specialists involved in treating severe acute PE. This model of care provides a platform for rapid decisions on individualized treatment strategies, combining expert opinion from all involved specialties, setting the quality standards for modern local and regional equity PE care, and forming the base for future research in this area. Clinical decisions should be evidence-based where possible, and incorporate the individual patient's and their carer's preferences, values, and priorities, as well as those of the managing clinicians and care team. In this review, we summarize the evidence for the introduction of EXPERT-PE care teams and provide a practical manual for their successful implementation.</p>","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":""},"PeriodicalIF":4.6,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145388092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The COR Lipid-Registry: The effectiveness of the strike early and strike strong strategy (SES) in patients with high cardiovascular risk. COR血脂登记:早打击和强打击策略(SES)在高心血管风险患者中的有效性。
IF 4.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-28 DOI: 10.1093/ehjacc/zuaf137
Patrick Weltler, Paul F Harbich, Achim Burger, Stephan Dobner, Christoph C Kaufmann, Alexander Geppert, Kurt Huber, Edita Pogran
<p><strong>Introduction: </strong>According to real world data only up to 20 % of patients with atherosclerotic cardiovascular disease (ASCVD) are below the recommended LDL-cholesterol (LDL-C) target of < 55mg/dl (<1.4 mmol/L) 1-3 months after the index event. Accordingly, improved strategies for initiating lipid-lowering therapy (LLT) are desired to achieve treatment targets required to further reduce future cardiovascular event rates.</p><p><strong>Materials and methods: </strong>The COR Lipid Registry included patients at very-high cardiovascular (CV) risk presenting for percutaneous coronary intervention (PCI) with acute (ACS) or chronic (CCS) coronary syndrome. Coronary artery disease (CAD) patients with an LDL-C level of >130 mg/dL (equalizing 3.37 mmol/L), or a non-HDL of 160mg/dL (equalizing 4.14 mmol/L) either LLT-naïve or with suboptimal LLT at index hospitalization were enrolled. Based on lipid levels at baseline, these patients were assumed to need triple LLT to achieve their LDL-C target. Baseline characteristics and lipid parameters of all patients were collected at index hospitalization and 2 follow-up visits, after 4-6 and 8-12 weeks, respectively. Initially, in all patients a dual LLT (high-dose, highly effective statin, which means atorvastatin 40mg or 80mg and rosuvastatin 20mg or 40mg, plus ezetimibe) was initiated during the index hospitalization, before PCSK9-inhibitors or bempedoic acid were added, if LDL-C target levels were not met at control visits.</p><p><strong>Results: </strong>In total, 165 very-high-risk patients were included, of which 79 (42.0%) were admitted for CCS, and 109 (58%) for ACS, respectively. At visit 1, 114 (69.1%) patients reached the recommended (ESC/EAS guidelines 2019) lipid goals (LDL-C of < 55 mg/dl; equalising 1.4 mmol/L; or non-HDL-C of 85 mg/dl equalizing 2.2 mmol/<L), while 160 patients (97%) met the target at visit 2. In ACS patients, 74.3% reached the recommended treatment goal (LDL-C or non-HDL-C) at visit 1 and 97.3% at visit 2. In CCS patients, the treatment goal was achieved in 60.8% at visit 1 and 100% at visit 2, respectively. In the LLT-naïve group at admission (n=64), the treatment goal was met in 61.5% of patients at visit 1 and in 96.9% of patients at visit 2, while for LLT-pre-treated patients, the respective data were 76.3% and 100%, respectively.</p><p><strong>Summary: </strong>An optimized LLT-strategy for managing a very-high CV risk patient cohort undergoing PCI, starting with a dual LLT-strategy consisting of a high-dose, highly effective statin plus ezetimibe at the index event followed by addition of a third LL-agent (a PCSK9-inhibitor or bempedoic acid) at follow-up after 4-6 weeks if treatment goal was not reached, was highly effective in achieving LDL-C and non-HDL-C goals. Wider adoption of this strategy may help to significantly improve LDL-C-target levels in real-world populations in very-high risk CAD patients presenting with ACS or CCS for coronary revascularisat
简介:根据现实世界的数据,只有高达20%的动脉粥样硬化性心血管疾病(ASCVD)患者低于推荐的ldl -胆固醇(LDL-C)目标< 55mg/dl(材料和方法:COR脂质登记包括心血管(CV)风险非常高的患者,急性(ACS)或慢性(CCS)冠状动脉综合征的经皮冠状动脉介入治疗(PCI)。冠状动脉疾病(CAD)患者在入院时LDL-C水平为bb0 130 mg/dL(等于3.37 mmol/L),或非hdl为160mg/dL(等于4.14 mmol/L) LLT-naïve或LLT不理想。根据基线的脂质水平,假设这些患者需要三次LLT才能达到LDL-C目标。所有患者分别在4-6周和8-12周的指数住院和2次随访时收集基线特征和脂质参数。最初,如果在对照就诊时LDL-C目标水平未达到,所有患者在指数住院期间开始双LLT(高剂量、高效的他汀类药物,即阿托伐他汀40mg或80mg和瑞舒伐他汀20mg或40mg,加依zetimibe),然后添加pcsk9抑制剂或苯甲多酸。结果:共纳入165例高危患者,其中79例(42.0%)因CCS入院,109例(58%)因ACS入院。在访问时,1114例(69.1%)患者达到了推荐的(ESC/EAS指南2019)脂质目标(LDL-C < 55 mg/dl,均衡1.4 mmol/L;摘要:一项用于管理接受PCI的非常高CV风险患者队列的优化llt策略,从双llt策略开始,包括在指数事件时高剂量,高效的他汀类药物加依zetimibe,然后在随访4-6周后,如果治疗目标未达到,则添加第三种llt药物(pcsk9抑制剂或苯甲多酸),在实现LDL-C和非hdl - c目标方面非常有效。广泛采用这一策略可能有助于显著提高现实人群中以ACS或CCS为冠脉重建术的高危冠心病患者的ldl - c目标水平。
{"title":"The COR Lipid-Registry: The effectiveness of the strike early and strike strong strategy (SES) in patients with high cardiovascular risk.","authors":"Patrick Weltler, Paul F Harbich, Achim Burger, Stephan Dobner, Christoph C Kaufmann, Alexander Geppert, Kurt Huber, Edita Pogran","doi":"10.1093/ehjacc/zuaf137","DOIUrl":"https://doi.org/10.1093/ehjacc/zuaf137","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;According to real world data only up to 20 % of patients with atherosclerotic cardiovascular disease (ASCVD) are below the recommended LDL-cholesterol (LDL-C) target of &lt; 55mg/dl (&lt;1.4 mmol/L) 1-3 months after the index event. Accordingly, improved strategies for initiating lipid-lowering therapy (LLT) are desired to achieve treatment targets required to further reduce future cardiovascular event rates.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Materials and methods: &lt;/strong&gt;The COR Lipid Registry included patients at very-high cardiovascular (CV) risk presenting for percutaneous coronary intervention (PCI) with acute (ACS) or chronic (CCS) coronary syndrome. Coronary artery disease (CAD) patients with an LDL-C level of &gt;130 mg/dL (equalizing 3.37 mmol/L), or a non-HDL of 160mg/dL (equalizing 4.14 mmol/L) either LLT-naïve or with suboptimal LLT at index hospitalization were enrolled. Based on lipid levels at baseline, these patients were assumed to need triple LLT to achieve their LDL-C target. Baseline characteristics and lipid parameters of all patients were collected at index hospitalization and 2 follow-up visits, after 4-6 and 8-12 weeks, respectively. Initially, in all patients a dual LLT (high-dose, highly effective statin, which means atorvastatin 40mg or 80mg and rosuvastatin 20mg or 40mg, plus ezetimibe) was initiated during the index hospitalization, before PCSK9-inhibitors or bempedoic acid were added, if LDL-C target levels were not met at control visits.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;In total, 165 very-high-risk patients were included, of which 79 (42.0%) were admitted for CCS, and 109 (58%) for ACS, respectively. At visit 1, 114 (69.1%) patients reached the recommended (ESC/EAS guidelines 2019) lipid goals (LDL-C of &lt; 55 mg/dl; equalising 1.4 mmol/L; or non-HDL-C of 85 mg/dl equalizing 2.2 mmol/&lt;L), while 160 patients (97%) met the target at visit 2. In ACS patients, 74.3% reached the recommended treatment goal (LDL-C or non-HDL-C) at visit 1 and 97.3% at visit 2. In CCS patients, the treatment goal was achieved in 60.8% at visit 1 and 100% at visit 2, respectively. In the LLT-naïve group at admission (n=64), the treatment goal was met in 61.5% of patients at visit 1 and in 96.9% of patients at visit 2, while for LLT-pre-treated patients, the respective data were 76.3% and 100%, respectively.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Summary: &lt;/strong&gt;An optimized LLT-strategy for managing a very-high CV risk patient cohort undergoing PCI, starting with a dual LLT-strategy consisting of a high-dose, highly effective statin plus ezetimibe at the index event followed by addition of a third LL-agent (a PCSK9-inhibitor or bempedoic acid) at follow-up after 4-6 weeks if treatment goal was not reached, was highly effective in achieving LDL-C and non-HDL-C goals. Wider adoption of this strategy may help to significantly improve LDL-C-target levels in real-world populations in very-high risk CAD patients presenting with ACS or CCS for coronary revascularisat","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":""},"PeriodicalIF":4.6,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145388150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fostering Psychological Safety and Resilience in the ICU: Implementing Structured Peer Support. 在ICU培养心理安全和恢复力:实施结构化同伴支持。
IF 4.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-16 DOI: 10.1093/ehjacc/zuaf132
Tharusan Thevathasan, Michelle Roßberg, Esteban Mery-Fernandez, Janine Pöss, Hannah Schaubroeck, Jacob C Jentzer

Psychological distress, moral injury and burnout are prevalent among intensive care unit (ICU) professionals, impacting individual well-being, team dynamics and patient safety. Structured peer support programs, delivered by trained colleagues rather than mental health professionals, could be implemented as low-threshold, scalable interventions to promote psychological safety and resilience. This review outlines five foundational pillars for implementing peer support in the ICU, including formal program design, training, inclusivity, confidentiality and continuous evaluation. It also addresses practical strategies to overcome cultural and institutional barriers, such as stigma, time constraints and hierarchical norms. Drawing on current evidence and recent unpublished survey data from North American critical care cardiologists, the article provides a practical framework for integrating peer support into ICU culture. Peer support represents a complementary approach to formal mental health services and offers tangible benefits for clinician well-being, retention and quality of care.

心理困扰、道德伤害和倦怠在重症监护病房(ICU)专业人员中普遍存在,影响个人福祉、团队动力和患者安全。由训练有素的同事而不是心理健康专业人员提供的结构化同伴支持方案,可以作为低门槛、可扩展的干预措施实施,以促进心理安全和复原力。本文概述了在ICU实施同伴支持的五个基本支柱,包括正式的方案设计、培训、包容性、保密性和持续评估。它还涉及克服文化和体制障碍的实际战略,如耻辱、时间限制和等级规范。根据目前的证据和北美重症心脏病专家最近未发表的调查数据,本文提供了一个将同伴支持融入ICU文化的实用框架。同伴支持是对正式精神卫生服务的一种补充,为临床医生的福祉、保留和护理质量提供了切实的好处。
{"title":"Fostering Psychological Safety and Resilience in the ICU: Implementing Structured Peer Support.","authors":"Tharusan Thevathasan, Michelle Roßberg, Esteban Mery-Fernandez, Janine Pöss, Hannah Schaubroeck, Jacob C Jentzer","doi":"10.1093/ehjacc/zuaf132","DOIUrl":"https://doi.org/10.1093/ehjacc/zuaf132","url":null,"abstract":"<p><p>Psychological distress, moral injury and burnout are prevalent among intensive care unit (ICU) professionals, impacting individual well-being, team dynamics and patient safety. Structured peer support programs, delivered by trained colleagues rather than mental health professionals, could be implemented as low-threshold, scalable interventions to promote psychological safety and resilience. This review outlines five foundational pillars for implementing peer support in the ICU, including formal program design, training, inclusivity, confidentiality and continuous evaluation. It also addresses practical strategies to overcome cultural and institutional barriers, such as stigma, time constraints and hierarchical norms. Drawing on current evidence and recent unpublished survey data from North American critical care cardiologists, the article provides a practical framework for integrating peer support into ICU culture. Peer support represents a complementary approach to formal mental health services and offers tangible benefits for clinician well-being, retention and quality of care.</p>","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":""},"PeriodicalIF":4.6,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145299267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe acute kidney injury in the intensive care unit: step-to-step management. 重症监护病房的严重急性肾损伤:分步管理。
IF 4.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-12 DOI: 10.1093/ehjacc/zuaf084
Mauro Riccardi, Matteo Pagnesi, Carlo M Lombardi, Marco Metra

Acute kidney injury (AKI) is a sudden loss of renal function limited to 7 days with increased basal serum creatinine levels and/or decreased urinary production. AKI is a frequent condition in the intensive care unit (ICU) ranging from 13% to 36% in patients hospitalized with acute heart failure, up to 80% in patients with cardiogenic shock (CS). AKI requiring dialysis is also common (5% to 8%) and can exceed 13% in patients with CS. AKI is consistently associated with increased mortality in both the short-term, especially when dialysis is needed, and the long-term. The aim of this review is to provide an update on step-by-step management, from pharmacological treatment to renal replacement therapy, in patients with severe AKI in ICU patients with fluid overload.

急性肾损伤(AKI)是一种持续7天的突然肾功能丧失,伴有基础血清肌酐水平升高和/或尿量减少。AKI是重症监护病房(ICU)的常见疾病,在急性心力衰竭住院患者中发生率为13%至36%,在心源性休克(CS)患者中高达80%。需要透析的AKI也很常见(5% - 8%),在CS患者中可超过13%。AKI在短期内(特别是需要透析时)和长期内均与死亡率增加相关。本综述的目的是为ICU中液体负荷过重的严重AKI患者提供从药物治疗到肾脏替代治疗的逐步管理的最新进展。
{"title":"Severe acute kidney injury in the intensive care unit: step-to-step management.","authors":"Mauro Riccardi, Matteo Pagnesi, Carlo M Lombardi, Marco Metra","doi":"10.1093/ehjacc/zuaf084","DOIUrl":"10.1093/ehjacc/zuaf084","url":null,"abstract":"<p><p>Acute kidney injury (AKI) is a sudden loss of renal function limited to 7 days with increased basal serum creatinine levels and/or decreased urinary production. AKI is a frequent condition in the intensive care unit (ICU) ranging from 13% to 36% in patients hospitalized with acute heart failure, up to 80% in patients with cardiogenic shock (CS). AKI requiring dialysis is also common (5% to 8%) and can exceed 13% in patients with CS. AKI is consistently associated with increased mortality in both the short-term, especially when dialysis is needed, and the long-term. The aim of this review is to provide an update on step-by-step management, from pharmacological treatment to renal replacement therapy, in patients with severe AKI in ICU patients with fluid overload.</p>","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":"618-630"},"PeriodicalIF":4.6,"publicationDate":"2025-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144511718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New clinical research in post-resuscitation care: prognostication, physiology, and patient-centred outcomes. 社论:复苏后护理的新临床研究——预后、生理学和以患者为中心的结果。
IF 4.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-12 DOI: 10.1093/ehjacc/zuaf113
Johannes Grand, Janine Pöss
{"title":"New clinical research in post-resuscitation care: prognostication, physiology, and patient-centred outcomes.","authors":"Johannes Grand, Janine Pöss","doi":"10.1093/ehjacc/zuaf113","DOIUrl":"10.1093/ehjacc/zuaf113","url":null,"abstract":"","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":"590-592"},"PeriodicalIF":4.6,"publicationDate":"2025-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144947532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Answer: Three thunderclaps in a quiescent myocardium. 答:静止的心肌中有三声雷鸣。
IF 4.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-12 DOI: 10.1093/ehjacc/zuaf055
Simon Fitouchi, Halim Marzak, Laurence Jesel
{"title":"Answer: Three thunderclaps in a quiescent myocardium.","authors":"Simon Fitouchi, Halim Marzak, Laurence Jesel","doi":"10.1093/ehjacc/zuaf055","DOIUrl":"10.1093/ehjacc/zuaf055","url":null,"abstract":"","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":"633-634"},"PeriodicalIF":4.6,"publicationDate":"2025-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12515086/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145211912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Question: Three thunderclaps in a quiescent myocardium. 问:静止心肌中有三次雷击。
IF 4.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-12 DOI: 10.1093/ehjacc/zuaf054
Simon Fitouchi, Halim Marzak, Laurence Jesel
{"title":"Question: Three thunderclaps in a quiescent myocardium.","authors":"Simon Fitouchi, Halim Marzak, Laurence Jesel","doi":"10.1093/ehjacc/zuaf054","DOIUrl":"10.1093/ehjacc/zuaf054","url":null,"abstract":"","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":"631-632"},"PeriodicalIF":4.6,"publicationDate":"2025-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12515085/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145148417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early repolarization pattern in post-resuscitation electrocardiogram and outcomes in cardiac arrest survivors: a propensity score matching analysis. 复苏后心电图早期复极模式和心脏骤停幸存者的预后:倾向评分匹配分析。
IF 4.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-12 DOI: 10.1093/ehjacc/zuaf066
Dongju Kim, Dong Hun Lee, Hanna Park, Yong Hun Jung, Byung Kook Lee, Won Young Kim

Aims: Early repolarization patterns (ERPs) are a known risk factor for sudden cardiac death; however, their prognostic significance in cardiac arrest survivors remains unclear. This study aimed to investigate the clinical characteristics and outcomes of ERP in post-cardiac arrest survivors.

Methods and results: This observational cohort study included adult out-of-hospital cardiac arrest survivors (aged ≥18 years) who underwent targeted temperature management at two South Korean tertiary care centres between February 2018 and May 2023. Clinical, electrocardiogram (ECG), and outcome characteristics were compared between patients with and without ERP. Propensity score matching (PSM) was used to minimize confounding, followed by logistic regression analysis. The primary outcome was survival until the hospital discharge. Among the 693 post-resuscitation patients, 127 (18.3%) had ERP. The ERP cohort was characterized by a younger average age (59.0 vs. 64.1 years) and had lower peak levels of troponin I (1.7 vs. 4.5) and creatinine (1.2 vs. 1.4). Multivariable logistic regression analysis revealed that the ERP independently predicted decreased mortality at discharge (odds ratio: 1.68; 95% confidence interval: 1.04-2.72; P = 0.034) after adjusting for potential confounders. However, the difference in achieving favourable neurological outcomes was not statistically significant. These results were consistent within the matched cohort. After matching, groups showed no significant differences in post-resuscitation care variables or adverse events, except for maximum vasopressor doses.

Conclusion: The presence of ERP in post-resuscitation ECG was associated with a greater likelihood of survival until hospital discharge.

背景:早期复极模式(ERP)是已知的心源性猝死的危险因素;然而,它们在心脏骤停幸存者中的预后意义尚不清楚。本研究旨在探讨心脏骤停后幸存者ERP的临床特征和预后。方法:本观察性队列研究纳入了2018年2月至2023年5月期间在韩国两家三级医疗中心接受定向体温管理的院外心脏骤停成人幸存者(年龄≥18岁)。比较有和无ERP患者的临床、心电图和结局特征。采用倾向评分匹配(PSM)最小化混杂因素,然后进行逻辑回归分析。主要结局是存活至出院。结果:693例复苏后患者中,有127例(18.3%)出现ERP。ERP队列的特点是平均年龄较年轻(59.0岁对64.1岁),肌钙蛋白I(1.7对4.5)和肌酐(1.2对1.4)的峰值水平较低。多变量logistic回归分析显示,ERP模式独立预测出院时死亡率降低(优势比:1.68;95%置信区间:1.04-2.72;P =0.034),校正了潜在的混杂因素。然而,在获得良好的神经预后方面的差异没有统计学意义。这些结果在匹配的队列中是一致的。配对后,各组复苏后护理变量或不良事件没有显著差异,除了最大血管加压剂剂量。结论:复苏后心电图中ERP的存在与更大的存活至出院的可能性相关。
{"title":"Early repolarization pattern in post-resuscitation electrocardiogram and outcomes in cardiac arrest survivors: a propensity score matching analysis.","authors":"Dongju Kim, Dong Hun Lee, Hanna Park, Yong Hun Jung, Byung Kook Lee, Won Young Kim","doi":"10.1093/ehjacc/zuaf066","DOIUrl":"10.1093/ehjacc/zuaf066","url":null,"abstract":"<p><strong>Aims: </strong>Early repolarization patterns (ERPs) are a known risk factor for sudden cardiac death; however, their prognostic significance in cardiac arrest survivors remains unclear. This study aimed to investigate the clinical characteristics and outcomes of ERP in post-cardiac arrest survivors.</p><p><strong>Methods and results: </strong>This observational cohort study included adult out-of-hospital cardiac arrest survivors (aged ≥18 years) who underwent targeted temperature management at two South Korean tertiary care centres between February 2018 and May 2023. Clinical, electrocardiogram (ECG), and outcome characteristics were compared between patients with and without ERP. Propensity score matching (PSM) was used to minimize confounding, followed by logistic regression analysis. The primary outcome was survival until the hospital discharge. Among the 693 post-resuscitation patients, 127 (18.3%) had ERP. The ERP cohort was characterized by a younger average age (59.0 vs. 64.1 years) and had lower peak levels of troponin I (1.7 vs. 4.5) and creatinine (1.2 vs. 1.4). Multivariable logistic regression analysis revealed that the ERP independently predicted decreased mortality at discharge (odds ratio: 1.68; 95% confidence interval: 1.04-2.72; P = 0.034) after adjusting for potential confounders. However, the difference in achieving favourable neurological outcomes was not statistically significant. These results were consistent within the matched cohort. After matching, groups showed no significant differences in post-resuscitation care variables or adverse events, except for maximum vasopressor doses.</p><p><strong>Conclusion: </strong>The presence of ERP in post-resuscitation ECG was associated with a greater likelihood of survival until hospital discharge.</p>","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":"610-617"},"PeriodicalIF":4.6,"publicationDate":"2025-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143973759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Heart Journal: Acute Cardiovascular Care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1